Market Snapshot

S&P Futures
Dow Futures
NASDAQ Futures

Atara Biotherapeutics, Inc.   NASDAQ (ATRA)

15.62    $-0.41   -2.56%
Market open   Monday, Oct 25 2021 13:05 PM

Atara Biotherapeutics, Inc. Chart

ATRA Stock Price Today

Atara Biotherapeutics, Inc. (ATRA) stock plummeted over -2.56% intraday to trade at $15.62 a share on NASDAQ. The stock opened with a gain of 0.25% at $16.07 and touched an intraday high of $16.07, rising 0.25% against the last close of $16.03. The stock went to a low of $15.47 during the session.

Stock Snapshot

16.03
Prev. Close
16.07
Open
1.34B
Market Cap
92.15M
Number of Shares
15.47
day Low
16.07
Day High
15.62
-
P/E ratio
13.91%
Free Float in %
-3.63
EPS (TTM)
3.60
Book Value per Share
4.47
Cash Flow per Share
124526
Volume

Atara Biotherapeutics, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-10-21$15.71$15.81$15.97$15.45496,400
2021-10-20$15.02$15.71$15.82$15.02533,200
2021-10-19$14.67$15.13$15.17$14.41842,800
2021-10-18$15.07$14.70$15.28$14.55628,500
2021-10-15$15.95$15.12$15.97$15.10798,100
2021-10-14$15.87$15.76$15.98$15.011,442,100
2021-10-13$17.90$15.66$17.97$15.341,837,800
2021-10-12$16.97$17.98$18.01$16.811,156,600
2021-10-11$17.15$16.93$17.22$16.83509,100
2021-10-08$17.57$17.05$17.57$16.91547,900
2021-10-07$17.46$17.62$17.76$17.30757,000

Contact Details

611 Gateway Boulevard
Suite 900
South San Francisco, CA 94080
United States
http://www.atarabio.com
650 278 8930

Company Information

Employees437
Beta2.06
Sales or Revenue7.40M
5Y Sales Change-%
Fiscal Year Ends2020-12-30
SectorHealthcare
IndustryBiotechnology

About Company

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA2321 for acute myeloid leukemia; and ATA368 for human papillomavirus. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Frequently Asked Questions

What is the current Atara Biotherapeutics, Inc. (ATRA) stock price?

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) stock price is $15.62 as of the last check on Monday, Oct 25 2021. During the trading session, ATRA stock reached the peak price of $16.07 while $15.47 was the lowest point it dropped to.

ATRA's industry and sector of operation?

The NASDAQ listed ATRA is part of Biotechnology industry that operates in the broader Healthcare sector. Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States.

Who are the executives of ATRA?

Dr. Pascal Touchon D.V.M.
Pres, CEO & Director

Mr. Utpal Koppikar
Chief Financial Officer

Mr. Joseph Newell
Exec. VP & COO

Eric Hyllengren
Head of Investor Relations & Fin.


What is the ATRA stock price today?

ATRA stock is trading at $15.62 today, which is $-0.41 or -2.56% lower than its previous close of $16.03. ATRA's current trading price is -44.75% lower than its 52-week high of $28.20 where as its distance from 52-week low of $11.81 is 31.92%.

How many employees does ATRA have?

Number of ATRA employees currently stands at 437. ATRA operates from 611 Gateway Boulevard Suite 900 South San Francisco, CA 94080 United States.

Link for ATRA official website?


How do I contact ATRA?

ATRA could be contacted at 611 Gateway Boulevard Suite 900 South San Francisco, CA 94080 United States, or at phone # 650 278 8930 and can also be accessed through its website: http://www.atarabio.com

How many shares of ATRA are traded daily?

ATRA stock volume so far today is 124526 shares while in the previous session number of ATRA shares traded was 496400. The average number of ATRA shares traded daily for last 3 months was 756980.

How much did ATRA change today?

The percentage change in ATRA stock occurred in the recent session was -2.56% while the dollar amount for the price change in ATRA stock was $-0.41.

What price range ATRA stock been trading in?

In the recent session, the day high for ATRA stock was $16.07 while the low for ATRA stock touched on the day was $15.47.

What is the market cap of ATRA currently?

The market value of ATRA currently stands at $1.34B with its latest stock price at $15.62 and 92.15M of its shares outstanding.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam